C
hronic lymphedema is a debilitating disorder that occurs commonly after lymph node dissection for breast cancer and other malignancies. In the United States alone, it is estimated that lymphedema affects nearly 2 million patients. 1 Lymphedema has a significant negative impact on quality of life by impairing limb function and appearance. 2 Despite the prevalence and morbidity of lymphedema, there are no proven preventative measures, with most currently available treatment options being symptomatic and noncurative. Surgical treatments have been described; however, they have not gained widespread acceptance or use.
The development of lymphatic-specific markers has fostered significant research and improved our understanding of the molecular mechanisms regulating lymphangiogenesis. Based on these studies, it is clear that formation of new lymphatic capillaries is complex and requires precisely timed orchestration of both cellular and molecular events. However, the pathologic changes in these pathways leading to abnormal lymphatic regeneration and ultimately lymphedema remain unknown.
Clinical studies have demonstrated a significant link between fibrosis and the development of lymphedema. 3 For instance, it is commonly known that patient or treatment factors that promote scarring and fibrosis, such as radiation therapy, 4 infections, or extensive surgical resection, 5 are associated with an increased incidence of lymphedema. Fibrosis, defined as excessive deposition of extracellular matrix products, is a well-known mechanism of organ dysfunction in a number of systems, including liver, kidney, heart, and skin. 6 -9 These facts have led us to hypothesize that fibrosis is a key etiologic component of abnormal lymphatic regeneration and subsequent lymphedema. The purpose of this study was therefore to evaluate the effects of fibrosis on lymphatic regeneration.
In this study, using a mouse lymphatic regeneration model, we demonstrate that inhibition of fibrosis dramatically accelerates lymphatic regeneration and decreases postsurgical acute lymphedema. This effect is attributable to improved lymphatic function and increased lymphatic endothelial cell proliferation. In addition, we demonstrate that fibrotic wound repair is associated with lymphatic vessel fibrosis and expression of ␣-smooth muscle actin by lymphatic endothelial cells. Improved lymphatic regeneration in wounds demonstrating decreased fibrosis was independent of vascular endothelial growth factor (VEGF) C expression. Collectively, our results suggest that decreasing fibrosis after surgery may be a viable means of improving lymphatic regeneration and can serve as a preventative measure in patients at risk for developing lymphedema. In addition, it may be useful to view dysfunctional lymphatic regeneration as a condition within the spectrum of fibroproliferative disorders.
MATERIALS AND METHODS

Mouse Tail Excision Model and Surgical Preparation
Acute lymphedema was established in the tails of 6-to 8-week-old female C57B6 mice (The Jackson Laboratory, Bar Harbor, Me.). After induction of anesthesia, a 2-mm-wide circumferential fullthickness skin excision was performed 20 mm from the mouse tail, removing the superficial lymphatic network as described previously. 10 The deep lymphatics were visualized using a surgical microscope (StereoZoom SZ-4; Leica, Wetzlar, Germany) and ligated, taking care not to injure the tail blood supply. The mice were divided into two groups (n ϭ 20 each). Based on previous studies, we found that filling the excisional wound with type I collagen significantly attenuated scarring in the wounds and promoted more rapid repair (not shown). 10 Therefore, to evaluate the effect of scarring on lymphatic regeneration, in group 1 (collagen) animals (experimental group) the skin defect was filled with 0.3% type I rat collagen gel (BD Biosciences, Bedford, Mass.). The wound was then dressed with Bacitracin Zinc Ointment USP (Fougera, Melville, N.Y.), wrapped with a 4-mm-wide piece of Xeroform Petrolatum Dressing (Cardinal Health, Dublin, Ohio), and then covered with a 6-cm-long piece of Tegaderm (3M, St. Paul, Minn.) to prevent desiccation and to keep the collagen gel in place. In preliminary experiments, we found that this treatment prevented wound desiccation and stayed in place for a period of 7 to 10 days (not shown). Group 2 animals (excision) underwent an identical skin and deep lymphatic excision and the wound was dressed identically; however, the wound defect was not filled with collagen type I. All animal procedures were approved by the Resource Animal Research Center Institutional Animal Care and Use Committee at Memorial Sloan-Kettering Cancer Center, New York, New York.
Specimen Preparation, Histology, Immunohistochemistry, and Immunofluorescent Staining
Ten-millimeter tail sections centered on the repair site were harvested at various time points after surgery (1, 2, 4, and 6 weeks) and fixed overnight at 4ºC in 4% paraformaldehyde. Specimens were then decalcified in Immunocal (Decal Chemical Corp., Tallman, N.Y.) for 2 to 3 days, embedded in paraffin, and sectioned longitudinally (5 m). Sections were stained with trichrome (Sigma, St. Louis, Mo.) using the manufacturer's protocol and evaluated using a Leica microscope.
Immunohistochemical and immunofluorescent staining was performed as previously described to localize lymphatic endothelial cells, growth factors, and myofibroblast markers. 11 Primary antibodies used were against lymphatic vessel endothelial receptor-1 (LYVE-1; rabbit polyclonal immunoglobulin G), ␣-smooth muscle actin, and proliferating cell nuclear antigen rabbit polyclonal (rabbit polyclonal immunoglobulin G; all from Abcam, Inc., Cambridge, Mass.). Immunofluorescent secondary antibodies used were fluorescein (R&D Systems, Minneapolis, Minn.) or Cy3 Zymed (Invitrogen Molecular Probes, Carlsbad, Calif.). VEGF-C immunohistochemistry was Volume 124, Number 2 • Scarring and Lymphatic Regeneration performed (goat polyclonal immunoglobulin G; Santa Cruz Biotechnology, Santa Cruz, Calif.). Secondary antibody was the Vectastain ABC Kit (Vector Laboratories, Burlingame, Calif.) and developed using diaminobenzidine. Images were obtained using bright-field microscopy (Leica TCS) for immunohistochemistry and a confocal microscope for immunofluorescence (Leica). VEGF-C expression was quantified using an analogue numerical scale by two blinded observers. Colocalization of immunofluorescent markers was performed using Metamorph Offline software (Molecular Devices Corp., Sunnyvale, Calif.).
Tail Volume Measurements
To evaluate the degree of postoperative acute lymphedema with or without excessive scarring, tail volumes were determined at 1, 2, 4, and 6 weeks in both groups (n ϭ 5 per group per time point). Tail circumference was measured at 10-mm intervals from the tail base using a digital caliper by blinded reviewers. Tail volumes were then calculated using the truncated cone formula: 
Lymphoscintigraphy
In an effort to quantify lymphatic transport after surgery with or without excessive scarring, technetium-99m/sulfur colloid (100-nm particle size; 400 to 800 Ci in approximately 50 l) was injected intradermally approximately 20 mm from the tail tip. Dynamic planar gamma camera images were acquired in 15-to 600-second frames for up to 2.5 hours after injection using an X-SPECT (Gamma Medica, Northridge, Calif.) fitted with low-energy parallel-hole collimators. Resulting dynamic images were analyzed using ASIPro (CTI Molecular Imaging, Knoxville, Tenn.), and region-of-interest analysis was performed to derive the decay-adjusted activity. Time-activity data were then fit to a flat line, a function exponentially decreasing to an asymptotic value for the injection site or a function exponentially increasing to an asymptotic value for the individual lymph nodes.
Analysis of Lymphatic Architecture and CrossSectional Lymphatic Vessel Diameter
Changes in lymphatic architecture proximal and distal to the operative site were assessed using fluorescent LYVE-1 staining. Two blinded investigators measured the cross sectional areas of LYVE-1-positive lymphatic vessels in four animals per group per time point using the formula r 1 r 2 (AxioVision Software, Göttinggen, Germany) as described previously. 13 Similarly, the number of lymphatic vessels in the distal portions of the wound were identified as LYVE-1-positive structures and counted using fluorescence microscopy in three random high-power fields per animal per time point (n ϭ 4 each; 100ϫ).
RNA Isolation and Quantitative Polymerase Chain Reaction
Three animals per time point per group were killed for RNA harvest, and quantitative polymerase chain reaction was performed using our previously published techniques.
14 Briefly, the wounded section and an area spanning approximately 1 mm proximal and 1 mm distal to the wound were harvested, rapidly frozen in liquid nitrogen, and homogenized in Trizol reagent (Invitrogen Molecular Probes), and total cellular RNA was harvested using the manufacturer's protocol. RNA quantity and quality of the purified samples was analyzed using a NanoDrop ND 1000 Spectrophotometer (NanoDrop Products, Wilmington, Del.). Reverse transcription was performed using the TaqMan Reverse Transcription Reagents Kit (Applied Biosystems, Foster City, Calif.) using 1 g of RNA. Quantitative reversetranscriptase polymerase chain reaction was then performed using the LightCycler thermocycler and the TaqMan Universal Mastermix (Roche Diagnostics Corp., Indianapolis, Ind.) according to the manufacturer's directions. A standard curve was prepared using serially diluted control samples and was plotted against cycle numbers obtained at log-linear phase of the reaction. Expression of LYVE-1, collagen I, and fibronectin (Applied Biosystems) was normalized to 18S RNA expression measured concurrently. Experiments were performed in triplicate.
Statistical Analysis
Statistical analysis was performed using GraphPad Prism (GraphPad Software, Inc., San Diego, Calif.) software for Windows. Comparative analysis between groups was performed using the MannWhitney test. Multigroup comparison was analyzed using the Kruskal-Wallis test with post hoc Dunn's multiple comparisons test. Mean values and standard deviations are presented, with values of p Ͻ 0.05 considered significant.
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RESULTS
Collagen Gel Treatment of Excisional Tail Wounds Is Associated with Decreased Fibrosis
Trichrome staining evaluation of mouse tail sections just distal to the surgical site, 6 weeks postoperatively, demonstrated decreased dermal and hypodermal thickening and fibrosis in the collagen group when compared with the excision group (Fig. 1) . With the trichrome stain, collagen deposition associated with fibrosis is seen as intense blue staining. In addition, the excision group sections were significantly more edematous and demonstrated ectatic lymphatics. These findings confirmed our previous study demonstrating decreased scarring and scar index using Sirius red staining.
10
Decreased Fibrosis Is Associated with Decreased Acute Postoperative Lymphedema, Increased Lymphatic Regeneration, and Improved Lymphatic Transport
To assess acute lymphedema after surgical ablation of the superficial and deep lymphatics, tail volume measurements were performed using the truncated cone formula and expressed as a function of preoperative volumes (i.e., percentage change) after 2, 4, and 6 weeks as described previously. 10 At all time points, the collagentreated tails demonstrated less lymphedema than the excision group. The differences in tail volumes were grossly obvious even at 6 weeks postoperatively (Fig. 2) . This difference was statistically significant, with tail volumes more than twofold lower at the 4-and 6-week time points Fig. 3 ). These findings confirmed our previous observations that tail excision in the mouse model causes reproducible tail lymphedema. Interestingly, the immunocompetent animals used in the current study versus nude mice in our previous study demonstrated greater tail edema in both groups (collagen and excision). 10 Decreases in tail volumes were corroborated by improved lymphatic function as assessed by lymphoscintigraphic uptake of technetium-99m by lymph nodes located at the base of the tail. This analysis demonstrated a statistically significant increase in both the rate and the absolute amount of uptake at all time points evaluated (Fig. 4) . Thus, decreasing fibrosis by collagen gel treatment significantly increases the rate of lymphatic transport in the mouse tail model of lymphatic regeneration.
To evaluate regeneration of lymphatic vessels in the setting of variable fibrosis, we evaluated both the number and the luminal diameter of LYVE-1-stained vessels. We noted a significant increase in the number of capillary lymphatics in the distal portion of collagen-treated wounds, with nearly twice as many vessels per high-power field Fig. 1 . Collagen gel treatment of excisional tail wounds is associated with decreased cutaneous scarring, decreased edema, and more normal appearing lymphatics. Representative micrographs (original magnification, ϫ50) of trichrome-stained mouse tail sections just distal to the surgical site, 6 weeks postoperatively, demonstrating decreased dermal and hypodermal thickening and fibrosis in the collagen group (group 1, left) when compared with the excision group (group 2, right). With the trichrome stain, collagen deposition associated with fibrosis is seen as intense blue staining (white arrow). In addition, the excision group sections were significantly more edematous and demonstrated ectatic lymphatics (black arrow).
Volume 124, Number 2 • Scarring and Lymphatic Regeneration as compared with the fibrotic excision-only sections (Fig. 5) . The increased number of lymphatic vessels mirrored our findings in the tail volumes and reached statistically significant levels at the 4-and 6-week time points. These findings were corroborated by the finding that the expression of the lymphatic endothelial cell-specific marker LYVE-1 was significantly higher by quantitative polymerase chain reaction in the collagen group (i.e., decreased fibrosis) as compared with the excision group (Fig. 6) .
LYVE-1 staining of the wound sections also enabled us to evaluate the microarchitecture of the newly formed lymphatic vessels. Interestingly, this analysis demonstrated that the lymphatic vessels present in the excision-only (i.e., fibrotic) group were dilated, ectatic, and abnormal appearing. In contrast, collagen-treated tails demonstrated normal-appearing collapsed lymphatics (Fig. 7) . This difference in lymphatic architecture correlates with impaired lymphatic transport and lymphedema and was apparent at all time points evaluated. Measurement of lymphatic vessel diameters confirmed these observations and demonstrated that collagen-treated tail wounds had significantly smaller (i.e., collapsed) lymphatics as compared with excision-only animals (p Ͻ 0.05 for all time points) (Fig. 8) .
Decreased Fibrosis and More Rapid Lymphatic Regeneration Are Associated with Decreased Expression of Extracellular Matrix Markers
To further quantify the expression of fibrosisassociated molecules within our model, we isolated total cellular RNA from mouse tail wounds and quantified collagen I and fibronectin I expression by quantitative polymerase chain reaction. Consistent with the finding of decreased fibrosis observed histologically, expression of the extracellular matrix components collagen I and Fig. 2 . Decreased scarring is associated with decreased acute postoperative lymphedema and increased lymphatic regeneration. Representative images of tails 6 weeks after surgery. Note that the collagen gel-treated tail is obviously less lymphedematous distal to the surgical wound than the excision-only tail. Notably, the collagen gel-treated wounds appear to have undergone more normal and complete wound healing at this late time point.
Fig. 3.
Change from baseline tail volumes was determined at various time points following operation using the truncated cone formula. This demonstrated that the collagen group had less lymphedema at all time points, a finding that achieved statistical significance at the later time points (*p Ͻ 0.05). Fig. 4 . Lymphatic function was evaluated by lymphoscintigraphy at 4 weeks after wounding. This demonstrated that the collagen group had significantly greater and more rapid lymph node uptake of a radioisotope-labeled colloid injected distal to the wound. This indicates that this group had better lymphatic function than the excision group. 
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Improved Lymphatic Regeneration and Function Associated with Decreased Scarring Is Not Associated with Alteration in VEGF-C Expression
No difference in VEGF-C expression was noted between collage gel-treated animals and excision animal wounds as assessed by immunohistochemistry in vivo (Fig. 11) . In both groups VEGF-C expression was noted in cells within the wound and the extracellular matrix; however, no significant differences in pattern or intensity of expression was noted. In both groups, VEGF-C expression was highest at 1 week postoperatively and decreased progressively.
Fibrotic Wound Repair Inhibits Lymphatic Endothelial Cell Proliferation
To evaluate potential mechanisms by which fibrosis could delay or inhibit lymphatic regeneration, we analyzed the proliferation of lymphatic endothelial cells present in the regenerating portion of the tail wounds using confocal microscopy with double staining for LYVE-1 (lymphatic-specific) and proliferating cell nuclear antigen (proliferation). This analysis demonstrated that the collagen-treated wounds (decreased fibrosis) had Fig. 7 . Decreased lymphedema is associated with decreased lymphatic congestion, as evidenced by decreased lymphatic dilation. Representative immunofluorescent micrograph of lymphatic vessels in the collagen and excision groups at 4 weeks after surgery. Lymphatic vessels were labeled with LYVE-1 (seen as red fluorescence). Note that in the collagen group the vessels are small and collapsed (arrow), whereas in the excision groups the lymphatics are ectatic (arrowhead). Fig. 8 . At all time points evaluated, the excision group animals had greater measured vessel areas, implying lymphatic vessel dilation as a consequence of lymphatic congestion.
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significantly increased numbers of proliferating lymphatic endothelial cells as compared with the excision-only wounds at all time points evaluated ( Fig. 12) (p Ͻ 0.01) . Interestingly, lymphatic endothelial cell proliferation in the collagen-treated wounds peaked at 2 weeks after surgery and preceded formation of increased numbers of lymphatic vessels noted in our vessel counts. These findings strongly corroborate our previous study in which we evaluated lymphatic endothelial cell proliferation only 2 weeks postoperatively (the point at which we noted the largest difference between the two groups). 10 The finding that collagen treatment increases lymphatic endothelial cell proliferation at all time points, even 6 weeks after surgery, is important because it implies that decreasing fibrosis leads to increased lymphatic vessel regeneration in the early period following wounding and remodeling during the later stages of repair.
Wound Fibrosis Is Associated with Coexpression of Lymphatic and Myofibroblast Markers
One of the hallmarks of lymphedema clinically is lymphatic fibrosis. 13 Therefore, to evaluate this phenomenon in our healing tail wounds, we colocalized the expression of the lymphatic endo- Fig. 9 . Decreased scarring and more rapid lymphatic regeneration are associated with decreased expression of extracellular matrix markers. Polymerase chain reaction analysis demonstrated that collagen I gene expression was up-regulated in the excision group wounds to a statistically significant effect at all time points. Collagen I expression increased with time. Fig. 10 . Polymerase chain reaction demonstrated that the excision groups had higher expression of fibronectin I, which achieved statistical significance by week 2 after surgery.
Volume 124, Number 2 • Scarring and Lymphatic Regeneration thelial cell marker LYVE-1 with the myofibroblast marker ␣-smooth muscle actin. This analysis demonstrated that although the newly formed lymphatic vessels in the collagen-treated animals were thin walled and lined with lymphatic endothelial cells that rarely coexpressed ␣-smooth muscle actin, excision-only animals demonstrated significantly thicker walled lymphatics and a marked increase in the number of LYVE-1/␣-smooth muscle actin double-positive cells (Fig. 13) . Using confocal laser microscopy to identify individual double-stained cells allowed us to quantify lymphatic endothelial cells that expressed ␣-smooth muscle actin. This analysis confirmed our previous qualitative observation that the expression of ␣-smooth muscle actin by lymphatic endothelial cells is significantly increased in a fibrotic wound. In the current study, we found a nearly fourfold increase in the number of double-positive lymphatic endothelial cells (i.e., coexpressing lymphatic and fibroblastic markers) in the excision group as compared with the collagen group at all time points evaluated (Fig. 14) (p Ͻ 0.01). It should be noted that, although collecting lymphatics are known to have surrounding myofibroblastlike cells and as such express ␣-smooth muscle actin, capillary lymphatics do not. Thus, the coexpression of ␣-smooth muscle actin by capillary lymphatics is a pathologic finding. Thus, wound fibrosis is associated with expression of fibroblast markers by lymphatic endothelial cells, suggesting that lymphatic fibrosis may result 
DISCUSSION
Clinical studies have demonstrated that the risk of lymphedema is increased significantly in patients who undergo therapies or complications that are associated with soft-tissue fibrosis. 4, 15, 16 For instance, postoperative infections and associated inflammation significantly increase the risk of lymphedema following axillary lymph node dissection. Similarly, radiation therapy when combined with axillary lymph node dissection increases the risk of lymphedema fourfold to eightfold. 4 Interestingly, radiation therapy alone only rarely (Ͻ5 percent) causes lymphedema, implying that radiation and its associated fibrosis impair lymphatic regeneration rather than significantly injuring existing lymphatic networks. This hypothesis is supported by the finding that lymphatic regeneration across scars is severely impaired and that fibrosis in a wound can be directly responsible for lymphedema and postoperative swelling. 17 These observations led us to hypothesize that fibrosis can both directly and indirectly inhibit lymphatic regeneration. Furthermore, we hypothesized that similar to many other fibroproliferative disorders, inhibition of lymphatic regeneration would be associated with alterations in extracellular matrix molecule gene expression. In support of our hypotheses, in the current study, we demonstrate that inhibition of fibrosis using a simple topical dressing significantly accelerates lymphangiogenesis in a wound-healing model of adult lymphatic regeneration.
Organ fibrosis is a common and often devastating problem. Examples of fibroproliferative disorders can be noted in virtually every major organ system, including liver (cirrhosis), lung (pulmonary fibrosis), heart, skin (scleroderma), and bone marrow. 6,8,18 -20 Fibrosis usually occurs as a result of injury; however, in some cases, the cause of fibrosis remains unclear (e.g., idiopathic pulmonary fibrosis). Numerous studies have attempted to delineate the molecular mechanisms of fibrotic disorders and have implicated alterations in the expression of profibrotic [e.g., transforming growth factor-␤1, interleukin (IL)-13, IL-4] and antifibrotic (e.g., IL-10, hepatocyte growth factor) growth factors and chemokines. 19, 21 These factors, together with circulating bone marrow-derived fibroblast-like cells (so-called fibrocytes), promote accumulation of extracellular matrix components, leading to a loss of normal organ architecture and ultimately dysfunction. [22] [23] [24] In this study, we provide evidence that acute lymphedema and delayed lymphatic regeneration during wound repair may also occur as a consequence of abnormal fibrosis, suggesting that lymphedema is a form of fibroproliferative disorder. In support of this, we show that fibrosis delays lymphatic transport and is associated with abnormal lymphatic architecture. These findings are important because they provide potential therapeutic and preventative strategies for patients who are at risk for developing lymphedema. These findings also strongly sup- Volume 124, Number 2 • Scarring and Lymphatic Regeneration Fig. 13 . Decreased cutaneous scarring inhibits lymphatic endothelial cell expression of fibroblast marker. LYVE-1 (red) and ␣-smooth muscle actin (green) immunofluorescent colocalization was performed in both groups, and representative 100ϫ micrographs at 4 weeks following surgery are presented. The insets represent magnified portions of the images for the purpose of facilitating visualization. Note that many of the lymphatics in the excision group coexpress LYVE-1 and ␣-smooth muscle actin as evidenced by yellow fluorescence. These lymphatics also demonstrate thickened walls, consistent with fibrosis (white arrow).
Plastic and Reconstructive Surgery • August 2009 port our previous findings that the expression of transforming growth factor-␤1, a critical profibrotic molecule, is associated with delayed lymphatic regeneration. 10 Several potential mechanisms may be responsible for delayed lymphatic regeneration in the setting of soft-tissue fibrosis. For instance, accumulation of extracellular matrix products or alterations in the ratio of these proteins as occurs during fibrosis and scarring may directly inhibit lymphatic endothelial cell proliferation. This conclusion is supported by our finding that lymphatic endothelial cell proliferation is significantly decreased in the excision group (i.e., fibrotic repair) as compared with the collagen geltreated (decreased fibrosis) group in vivo. It is possible that changes in the ratio or quantity of extracellular matrix proteins as occurs during scarring may inhibit lymphatic endothelial cell proliferation in vivo. Indeed, recent studies have demonstrated that the cellular response of lymphatic endothelial cells to growth factors such as VEGF-C can be altered by interactions with specific extracellular matrix proteins through interactions with integrin receptors. 25 This study demonstrated that lymphatic endothelial cell interaction with fibronectin can lead to enhanced phosphorylation of VEGF-R3 by VEGF-C, leading to improved lymphatic endothelial cell survival and proliferation and decreased apoptosis. Furthermore, another recent study demonstrated that extracellular matrix products can potently alter lymphatic endothelial cell migration and tubule formation. 26 Interestingly, in the current study, modulation of scarring altered lymphatic regeneration independent of VEGF-C expression. This suggests that fibrosis physically inhibits lymphatic channel creation or impacts the ability of VEGF-C to interact with VEGF-R3.
Clinically, it is known that lymphedema is associated with tissue fibrosis. 27, 28 More recently, anatomical studies on clinical specimens obtained years after axillary lymph node dissection have demonstrated fibrosis and thickening of lymphatic vessels distal to the dissection. 29 Ordinarily, lymphatic vessels are thinwalled capillaries with connections to the extracellular matrix. Distention of the extracellular matrix secondary to accumulation of interstitial fluid results in dilatation of the lymphatic capillaries and uptake of interstitial fluid by the lymphatics, with subsequent transport. Fibrosis of the lymphatic vessels may interfere with this process because it may result in a decreased potential for lymphatic vessels to dilate. In this study, we have shown that wound fibrosis and scarring is associated with lymphatic vessel fibrosis and thickening. Interestingly, this phenomenon was associated with increased numbers of lymphatic endothelial cells that coexpressed the activated fibroblast marker ␣-smooth muscle actin. Thus, lymphatic fibrosis may be a result of lymphatic endothelial cell production of fibroblast proteins or even endothelial-mesenchymal transdifferentiation. This phenomenon has been described in microvascular endothelial cells in a number of scenarios both in vivo and in vitro. 30 -34 In addition, numerous examples of epithelial-mesenchymal transdifferentiation have been reported.
CONCLUSIONS
We have shown that wound fibrosis is associated with a significant delay in lymphangiogenesis and impaired lymphatic function in a manner that may be independent of VEGF-C expression. These defects occur in part as a consequence of impaired lymphatic endothelial cell proliferation and abnormal lymphatic microarchitecture, resulting in di- Volume 124, Number 2 • Scarring and Lymphatic Regeneration
